| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| Other Sizes |
|
| ln Vitro |
Fast sodium channel blocker Nicainoprol, an antiarrhythmic medication, similarly prevents reperfusion arrhythmias in isolated rat hearts, although its effects on cardiac hemodynamics and biochemical markers are less pronounced than those of ACE inhibitors. No advantageous effects[1].
|
|---|---|
| ln Vivo |
In both anesthetized and isolated working rat hearts, the effects of the novel antiarrhythmic medication Nicainoprol on coronary artery blockage and reperfusion arrhythmias were investigated. Nicainoprol (10 μM, 5 μM, and 100 μM) produced concentration-related protection against reperfusion arrhythmias in isolated working rat hearts without changing cardiac dynamics, although heart rate was decreased at the highest dosages. Nicainoprol had no effect on the concentrations of glycogen, lactate, ATP, and creatine phosphate in cardiac tissue or the levels of the enzymes lactate dehydrogenase and creatine kinase in coronary venous effluent. The percentage of premature ventricular contractions (PVCs) and ventricular tachycardia in animals early post-occlusion (0-30 min) was dose-dependently decreased by administering Nicainoprol (5 and 10 mg/kg iv) to anesthetized rats. However, He was fully prevented from developing ventricular fibrillation. In 12% of rats treated with 10 mg/kg, compared with controls, animals treated with 5 mg/kg did not experience premature ventricular contractions, the only type of arrhythmia seen during this period. Rats have a 60% rate. Myocardial oxygen consumption, blood pressure, and heart rate all decreased with both nicanolol dosages. At the 5 mg/kg dose and the 10 mg/kg dose, there was a substantial 20% and 28% reduction in the ratio of infarct mass to ventricular mass, respectively. Cardiac arrhythmias related to acute myocardial infarction can be prevented and treated with nicanoprol [2].
|
| References |
|
| Molecular Formula |
C21H27N3O3
|
|---|---|
| Molecular Weight |
369.45738
|
| Exact Mass |
369.205
|
| CAS # |
76252-06-7
|
| PubChem CID |
71147
|
| Appearance |
White to off-white solid powder
|
| Density |
1.187g/cm3
|
| Boiling Point |
584.9ºC at 760 mmHg
|
| Flash Point |
307.6ºC
|
| Index of Refraction |
1.587
|
| LogP |
2.868
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
5
|
| Rotatable Bond Count |
7
|
| Heavy Atom Count |
27
|
| Complexity |
474
|
| Defined Atom Stereocenter Count |
0
|
| InChi Key |
AUIHHZBJBKRDIE-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C21H27N3O3/c1-15(2)23-13-18(25)14-27-19-9-3-6-16-8-5-11-24(20(16)19)21(26)17-7-4-10-22-12-17/h3-4,6-7,9-10,12,15,18,23,25H,5,8,11,13-14H2,1-2H3
|
| Chemical Name |
[8-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3,4-dihydro-2H-quinolin-1-yl]-pyridin-3-ylmethanone
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ≥ 29 mg/mL (~78.49 mM)
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.7067 mL | 13.5333 mL | 27.0665 mL | |
| 5 mM | 0.5413 mL | 2.7067 mL | 5.4133 mL | |
| 10 mM | 0.2707 mL | 1.3533 mL | 2.7067 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
